4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)
4:4 阿片类药物暴露和神经发育的调查 (iOPEN)
基本信息
- 批准号:9899554
- 负责人:
- 金额:$ 28.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-30 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:2 year oldAccelerationAddressAffectAgeAlcohol or Other Drugs useAssessment toolAttitudeBehavioralBiologicalBirthBrainCharacteristicsChildChildhoodCognitiveCollectionCommunitiesComplexDataData CollectionData QualityData SetDevelopmentDisadvantagedDropoutDropsEarly InterventionElectroencephalographyElementsEmotionalEnrollmentEnvironmental Risk FactorEthnic OriginEvaluationExposure toFamilyFathersFetal DevelopmentFetusFoundationsGoalsHealth SciencesHumanImageImage AnalysisInfantInfant HealthInstitutesInvestigationKnowledgeLeadLearningLinkLogisticsLong-Term EffectsLongitudinal StudiesLongitudinal SurveysLongitudinal cohort studyLongitudinal prospective studyMagnetic Resonance ImagingMeasurementMeasuresMedical centerMeta-AnalysisMethodologyMethodsModelingMonitorMotionMovementNeonatalNeonatal Abstinence SyndromeNew YorkNew York CityOpiate AddictionOpioidOpioid userOregonOutcomeParticipantPatientsPersonal SatisfactionPersonsPhasePopulationPopulation StudyPositioning AttributePregnancyPregnant WomenProbabilityProspective cohort studyProtocols documentationPsychosocial Assessment and CareRaceRecording of previous eventsResearchResearch DesignResearch PersonnelResourcesRisk FactorsRoleSavingsSiteSocioeconomic StatusStandardizationStructureTestingThird Pregnancy TrimesterTimeToddlerUltrasonographyUnited States National Institutes of HealthUniversitiesValidationVariantVermontWorkbiobehaviorcritical perioddata acquisitiondata collection methodologydata sharingdemographicsdesignearly childhoodefficacy testingexperiencefetalfetal drug exposurefetal opioid exposureflexibilityhealth assessmenthigh risk populationimprovedincentive strategiesinnovationlifestyle factorsmultidisciplinarymultimodalityneonatal magnetic resonance imagingneonateneurodevelopmentneuroimagingnovelopioid exposureopioid useopioid use in pregnancyphase 2 studypostnatalpreferencepregnantprenatalprospectiveprotective factorsrecruitresearch studyresilienceresponseretention ratesocialsuccesstoolusabilityyoung mother
项目摘要
PROJECT SUMMARY
While the rate of neonatal abstinence syndrome has reached a staggering 6.5 per 1,000 births nationwide, the
short- and long-term effects of opioid exposure are far from clear. We lack fundamental knowledge of
neurotypical neonatal development and struggle to disentangle the effect of opioid exposure from other
protective and risk factors impacting infant health. The fetal stage of brain development is a critical period
when foundational aspects of brain structure and function are being established. In addition, postnatal brain
development and specialization are shaped by environmental experiences thus allowing maturation to be
influenced by lifestyle factors associated with opioid use. This Phase I project will plan for a large scale, multi-
site research study to prospectively examine human brain, cognitive, behavioral, social, and emotional
development beginning prenatally through childhood. New York University is one of four linked applications
collaborating with investigators at Oregon Health and Sciences University, University of Pittsburgh Medical
Center and University of Vermont. Together, we will address key challenges that are critical to the success of
the planned Phase II study. Aim 1 will develop, implement and evaluate innovative recruitment and retention
strategies for high-risk populations. We will measure the feasibility, throughput, and demographic
characteristics associated with different recruitment methods through a longitudinal survey of 150 pregnant
women per site (n=600 across sites), half of whom use opioids during pregnancy. Aim 2 will implement a multi-
site, standardized, longitudinal research protocol by enrolling 20 pregnant women per site (n=80 across sites),
half of whom use opioids during pregnancy. This prospective longitudinal study will collect fetal and neonatal
multi-modal MRI, biospecimens, and maternal psychosocial and health assessments. Aim 3 will evaluate
innovative MRI acquisition and processing strategies and statistical considerations intended to address key
Phase II goals, including optimal measurement strategies and cross-site harmonization. Specifically, we will (a)
evaluate strategies for cross-scanner and cross-time image harmonization; (b) test real-time evaluation of MRI
data quality/motion during acquisition; (c) test the efficacy of accelerated image acquisition sequences; and (d)
build fetal and neonatal MRI processing pipelines. Our New York investigative team contributes extensive
experience leading studies in patients with opioid addiction, fetuses exposed to opioids, and longitudinal cohort
studies in pregnant patients, young children, and difficult to reach populations. We have directed multiple
consortia, performed large-scale population studies, and conducted multimodal MRI, EEG, and ultrasound
studies in fetuses, neonates, and children. Our prior expertise in longitudinal modelling of infant MRI data and
MRI methodology development suits us well to lead Aim 3's image harmonization and fetal/neonatal
processing pipeline development. Additionally, the New York City population brings much-needed diversity
across race, ethnicity, nativity, and socioeconomic status to the linked collaborative applications.
项目概要
尽管全国新生儿戒断综合症的发病率已达到惊人的每1000名新生儿中有6.5人,
接触阿片类药物的短期和长期影响尚不清楚。我们缺乏基本知识
神经典型的新生儿发育,并努力将阿片类药物暴露与其他药物的影响区分开来
影响婴儿健康的保护性和危险因素。胎儿阶段是大脑发育的关键时期
当大脑结构和功能的基础方面正在建立时。此外,产后大脑
发展和专业化是由环境经验塑造的,从而使成熟得以实现
受与阿片类药物使用相关的生活方式因素的影响。该项目一期将规划一个大规模、多用途的
前瞻性研究人类大脑、认知、行为、社交和情感的现场研究
发育从产前开始直至童年。纽约大学是四个链接申请之一
与俄勒冈健康与科学大学、匹兹堡大学医学院的研究人员合作
中心和佛蒙特大学。我们将共同应对对成功至关重要的关键挑战
计划的第二阶段研究。目标 1 将制定、实施和评估创新的招聘和保留
针对高危人群的策略。我们将衡量可行性、吞吐量和人口统计
通过对150名孕妇的纵向调查,与不同招募方式相关的特征
每个地点的女性(各地点 n=600),其中一半在怀孕期间使用阿片类药物。目标 2 将实施多项
站点,标准化纵向研究方案,每个站点招募 20 名孕妇(各站点 n=80),
其中一半在怀孕期间使用阿片类药物。这项前瞻性纵向研究将收集胎儿和新生儿
多模态 MRI、生物样本以及产妇心理社会和健康评估。目标 3 将评估
创新的 MRI 采集和处理策略以及统计考虑旨在解决关键问题
第二阶段目标,包括最佳测量策略和跨站点协调。具体来说,我们将 (a)
评估跨扫描仪和跨时间图像协调策略; (b) 测试MRI实时评估
采集过程中的数据质量/运动; (c) 测试加速图像采集序列的功效;和(四)
建立胎儿和新生儿 MRI 处理管道。我们的纽约调查团队做出了广泛的贡献
体验对阿片类药物成瘾患者、暴露于阿片类药物的胎儿和纵向队列的领先研究
针对孕妇、幼儿和难以接触人群的研究。我们曾指导过多个
联盟,进行大规模人群研究,并进行多模态 MRI、EEG 和超声检查
对胎儿、新生儿和儿童的研究。我们之前在婴儿 MRI 数据纵向建模方面的专业知识和
MRI 方法的开发非常适合我们领导 Aim 3 的图像协调和胎儿/新生儿
加工管道开发。此外,纽约市人口带来了急需的多样性
跨越种族、民族、出生地和社会经济地位来链接协作应用程序。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Veerle Bergink其他文献
Veerle Bergink的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Veerle Bergink', 18)}}的其他基金
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
产前母体感染和炎症对青春期人脑发育和精神病理学的影响
- 批准号:
10296635 - 财政年份:2021
- 资助金额:
$ 28.2万 - 项目类别:
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
产前母体感染和炎症对青春期人脑发育和精神病理学的影响
- 批准号:
10468261 - 财政年份:2021
- 资助金额:
$ 28.2万 - 项目类别:
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
产前母体感染和炎症对青春期人脑发育和精神病理学的影响
- 批准号:
10640239 - 财政年份:2021
- 资助金额:
$ 28.2万 - 项目类别:
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
怀孕期间停用抗抑郁药后复发的风险(R-DAP 研究)
- 批准号:
10569044 - 财政年份:2020
- 资助金额:
$ 28.2万 - 项目类别:
EXPOSURE TO TETRACYCLINE ANTIBIOTICS AND THE POTENTIAL PROTECTIVE EFFECT ON SCHIZOPHRENIA RISK.
接触四环素抗生素及其对精神分裂症风险的潜在保护作用。
- 批准号:
10039207 - 财政年份:2020
- 资助金额:
$ 28.2万 - 项目类别:
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
怀孕期间停用抗抑郁药后复发的风险(R-DAP 研究)
- 批准号:
10117285 - 财政年份:2020
- 资助金额:
$ 28.2万 - 项目类别:
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
怀孕期间停用抗抑郁药后复发的风险(R-DAP 研究)
- 批准号:
10334499 - 财政年份:2020
- 资助金额:
$ 28.2万 - 项目类别:
4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)
4:4 阿片类药物暴露和神经发育的调查 (iOPEN)
- 批准号:
10020516 - 财政年份:2019
- 资助金额:
$ 28.2万 - 项目类别:
4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)
4:4 阿片类药物暴露和神经发育的调查 (iOPEN)
- 批准号:
10321798 - 财政年份:2019
- 资助金额:
$ 28.2万 - 项目类别:
相似国自然基金
面向电力储能集群系统的加速退化试验与寿命评估方法研究
- 批准号:62303293
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向计算密集型应用的新型计算范式及其加速器关键技术
- 批准号:62374108
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于任意精度计算架构的量子信息处理算法硬件加速技术研究
- 批准号:62304037
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
分布式非凸非光滑优化问题的凸松弛及高低阶加速算法研究
- 批准号:12371308
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
极端光场条件下正电子束的产生、加速和操控研究
- 批准号:12375244
- 批准年份:2023
- 资助金额:53 万元
- 项目类别:面上项目
相似海外基金
Infant diet and cardiometabolic risk among children born preterm
早产儿的婴儿饮食和心脏代谢风险
- 批准号:
10716587 - 财政年份:2023
- 资助金额:
$ 28.2万 - 项目类别:
Development of translatable neurophysiological biomarkers to accelerate therapeutic development in Rett syndrome
开发可翻译的神经生理学生物标志物以加速雷特综合征的治疗开发
- 批准号:
10578522 - 财政年份:2023
- 资助金额:
$ 28.2万 - 项目类别:
Perinatal Experience and Epigenetic Change in Autism: Discovering Modifiable Pathways for Intervention
自闭症的围产期经历和表观遗传变化:发现可修改的干预途径
- 批准号:
10660207 - 财政年份:2023
- 资助金额:
$ 28.2万 - 项目类别:
Gaining insights: the effects of the RMK gain-of-function mutations on brain development and neurodevelopmental disorders
获得见解:RMK 功能获得性突变对大脑发育和神经发育障碍的影响
- 批准号:
10688073 - 财政年份:2022
- 资助金额:
$ 28.2万 - 项目类别:
Developing a Two-way SMS Platform to Prevent and Treat Wasting Among HIV-infected and HIV-exposed Uninfected Children
开发双向短信平台来预防和治疗艾滋病毒感染者和暴露于艾滋病毒的未感染儿童的消瘦
- 批准号:
10685330 - 财政年份:2022
- 资助金额:
$ 28.2万 - 项目类别: